Cone Health Becomes Third U.S. Customer
Filed with ASX · · 3 pages · English
PERTH, Australia, 23 December 2025: Artrya Limited (ASX: AYA) (Artrya or the Company), a medical technology company commercialising its Salix® AI-powered cloud platform, for the near real time, point of care assessment and management of coronary artery disease, is pleased to announce its third U.S. commercial customer, with the signing of a commercial agreement with Cone Health for the use of its
Earlier from Artrya
- First Revenues from Salix Coronary Plaque Module
- Second US Commercial Customer - Northeast Georgia
- S&P DJI Announces December 2025 Quarterly Rebalance
- SAPPHIRE Study Expands With Inclusion of Ascension
- Mass General Brigham to Participate in SAPPHIRE Study
Later from Artrya
- Quarterly Activities/Appendix 4C Cash Flow Report
- Appendix 4D and Interim Financial Report
- S&P DJI Announces March 2026 Quarterly Rebalance
- Update - S&P DJI March 2026 Rebalance of the All Ordinaries
- March Quarterly Activities Report and Appendix 4C
Follow Artrya into a list and get an email when it puts out news.
Follow Artrya